MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/85/0.1/20.12.24 Stock

Warrant

DE000MG4D203

Market Closed - Börse Stuttgart 14:56:48 2024-07-08 EDT
0.26 EUR -18.75% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/85/0.1/20.12.24
Current month-16.13%
1 month-70.79%
Date Price Change
24-07-08 0.26 -18.75%
24-07-05 0.32 0.00%
24-07-03 0.32 +3.23%
24-07-02 0.31 -11.43%
24-07-01 0.35 +12.90%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 02:56 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D20
ISINDE000MG4D203
Date issued 2024-05-16
Strike 85 $
Maturity 2024-12-20 (165 Days)
Parity 10 : 1
Emission price 2.24
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.25
Lowest since issue 0.26
Delta0.26x
Omega 4.581
Premium57.22x
Gearing17.86x
Moneyness 0.6595
Difference Strike 28.94 $
Difference Strike %+34.05%
Spread 0.04
Spread %12.90%
Theoretical value 0.2900
Implied Volatility 66.41 %
Total Loss Probability 86.45 %
Intrinsic value 0.000000
Present value 0.2900
Break even 88.14 €
Theta-0.02x
Vega0.01x
Rho0x

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.22 USD
Average target price
83.43 USD
Spread / Average Target
+45.81%
Consensus